Using deep transcranial magnetic stimulation to treat obsessive-compulsive disorder
Official title: A Preliminary Study on the Efficacy and Influencing Factors of Deep Transcranial Magnetic Stimulation in the Treatment of Obsessive-compulsive Disorder
Run by Shanghai Mental Health Center · NCT06692114 · Data updated 2026-11-12
This study is testing whether a new type of brain stimulation can help people with obsessive-compulsive disorder feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 70 (estimated) |
| Sponsor | Shanghai Mental Health Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | July 26, 2024 |
| Main results expected | June 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | August 15, 2025 |
| Trial ID | NCT06692114 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 50 with a diagnosis of OCD who have not adequately responded to standard treatments.
✕Probably not a fit
Patients with additional psychiatric disorders or severe physical illnesses that could interfere with treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of accelerated deep transcranial magnetic stimulation (dTMS) in treating patients with obsessive-compulsive disorder (OCD). Patients will be recruited from the Shanghai Mental Health Center and randomly assigned to either a real stimulation group or a sham stimulation group. The treatment involves administering dTMS twice daily for two weeks, with assessments conducted before and after treatment using EEG, MRI, cognitive tasks, and psychological scales to evaluate the treatment's impact and underlying neural mechanisms.
Why it matters
Potential benefit: If successful, this treatment could provide a new therapeutic option for patients with OCD who have not responded to traditional therapies.
How similar studies have gone: Previous studies have shown promising results with deep transcranial magnetic stimulation for various psychiatric conditions, suggesting potential efficacy in OCD as well.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged between 18 and 50, both genders are welcome. * DSM-5 criteria for OCD. * Y-BOCS total score ≥ 20 despite therapeutic-dose SRI treatment or completion of at least one full course of CBT. The treatment regimen must have been stable for at least 8 weeks prior to enrollment and remain unchanged throughout the study. * More than 9 years of education. * Right-handed. Exclusion Criteria: * Any additional current psychiatric comorbidity, except for obsessive- compulsive personality disorder. * Severe obsessive symptoms prevent the completion of necessary assessments. * Has a history of receiving ECT therapy. * Has received rTMS or tDCS treatment within the past two months. * Has severe physical illnesses or any physical conditions that can induce epilepsy or intracranial hypertension, including cardiovascular and respiratory diseases, among others. * Has a past history of neurological disorders (such as epilepsy, cerebrovascular accidents, etc.) or brain injuries, or a history of brain surgery. * Has implanted medical devices such as intracranial stents, cardiac pacemakers, coronary stents, cochlear implants, etc. * Serious suicide risk. * Pregnancy or nursing of an infant.
Where it's running
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Principal investigator: Zhen Wang, PhD,MD — Study Principal Investigato
- Study coordinator: Zhen W Wang, PhD,MD
- Email: wangzhen@smhc.org.cn
- Phone: +86 34773516
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Low-intensity focused ultrasound targeting the subthalamic nucleus for OCD
A short test is being done to see if a wearable, non-invasive ultrasound device can safely and tolerably help adults with OCD by targeting a brain region called the subthalamic nucleus.
-
Mindfulness-Based Cognitive Therapy for OCD Delivered Online
This study tests a synchronous online MBCT program for adults with OCD to see if it is acceptable and feasible and to explore links between biological markers, OCD severity, and treatment response.
-
Targeted brain stimulation for OCD: test of tTIS on nucleus accumbens
This study tests whether targeted temporal interference stimulation of the nucleus accumbens can help reduce obsessive-compulsive symptoms in adults with OCD, compared with sham stimulation.
-
Anxiety Skills Study: See if video skill training plus therapy helps people with anxiety
This study tests whether a brief video-based skill training can help people with anxiety as well as four therapy sessions, and how durable the effects are over a year.
-
AttunE LIFU for OCD: a non-invasive brain stimulation study
This trial tests ATTN201, a wearable ultrasound headband, to see if it helps adults with OCD compared to a sham treatment.
-
Combined ERP and Habit Reversal Therapy for Tourettic OCD
This study tests whether a merged Exposure and Response Prevention and Habit Reversal Therapy helps adults with Tourettic OCD more than either therapy alone or basic psychoeducation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.